CLINICAL_TRIALS
research
· 2025-11-25
Clinical Trial Update: Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy [NA]
Summary
This clinical trial is evaluating whether a late-evening and early-morning protein supplement can reduce readmissions in patients with hepatic encephalopathy. T…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Hepatic Encephalopathy | NA | Status: RECRUITING